首页|阿司匹林与氯吡格雷联合疏血通治疗对急性脑梗死患者血液流变学指标、神经功能及安全性的影响

阿司匹林与氯吡格雷联合疏血通治疗对急性脑梗死患者血液流变学指标、神经功能及安全性的影响

扫码查看
目的 探讨阿司匹林与氯吡格雷联合疏血通治疗对急性脑梗死(ACI)患者的影响.方法 选择2021年2月—2023 年 10 月兰陵县人民医院收治的 82 例ACI患者为研究对象,按照随机数字表法将其分为对照组和观察组,各41例.对照组予以阿司匹林与氯吡格雷治疗,观察组在对照组基础上加用疏血通治疗.比较两组的血液流变学指标、神经功能、生活质量及不良反应.结果 治疗14d后,观察组全血低切黏度为(9.57±0.74)mPa·s、血浆黏度为(1.58±0.11)mPa·s、纤维蛋白原为(3.01±0.03)g/L、全血高切黏度为(4.93±0.77)mPa·s、美国国立卫生研究院卒中量表为(7.22±1.08)分,均低于对照组的(10.87±0.82)mPa·s、(1.71±0.14)mPa·s、(4.52±0.07)g/L、(6.15±0.81)mPa·s、(9.84±2.76)分,组间差异有统计学意义(P<0.05);健康状况调查问卷中的总体健康为(70.28±5.31)分、生理机能为(71.58±5.88)分、躯体疼痛为(70.25±5.94)分、活力为(73.68±5.19)分,均高于对照组的(59.78±4.51)分、(58.44±4.69)分、(60.87±4.47)分、(52.87±4.49)分,组间差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论 将阿司匹林与氯吡格雷联合疏血通治疗ACI患者的效果明显,可减轻患者的神经损伤程度,改善机体内血液流变学指标,提高患者生活质量,且不会增加不良反应,安全性高.
Effects of Aspirin and Clopidogrel Combined with Shuxuetong Treatment on Hemorheological Indicators,Neurological Function and Safety In Patients with Acute Cerebral Infarction
Objective Exploring the effects of aspirin and clopidogrel combined with Shuxuetong treatment on patients with acute cerebral infarction(ACI).Methods Eighty-two ACI patients admitted to Lanling County People's Hospital February 2021 to October 2023 were selected as the research subjects,according to the random number table method,they were divided into a control group and an observation group,with 41 cases in each group.The control group was treated with aspirin and clopidogrel,while the observation group was treated with Shuxuetong in addition to the control group.Compare two groups of hemorheological indicators,neurological function,quality of life,and adverse reactions.Results After 14 days of treatment,the observation group had a whole blood low shear viscosity of(9.57±0.74)mPa·s,plasma viscosity of(1.58±0.11)mPa·s,fibrinogen of(3.01±0.03)g/L,whole blood high shear viscosity of(4.93±0.77)mPa·s,and National Institutes of Health Stroke Scale of(7.22±1.08)points,all of which were lower than the control group's(10.87±0.82)mPa·s,(1.71±0.14)mPa·s,and(4.52±0.07)g/L.(6.15±0.81)mPa·s,(9.84±2.76)points,the differences between groups were statistically significant(P<0.05);the overall health score in the 36-item Short Form Health Surve was(70.28±5.31)points,physiological function score was(71.58±5.88)points,physical pain score was(70.25±5.94)points,and vitality score was(73.68±5.19)points,all higher than the control group's(59.78±4.51)points,(58.44±4.69)points,(60.87±4.47)points,and(52.87±4.49)points,the differences between groups were statistically significant(P<0.05);comparison of incidence of adverse reactions between two groups,the difference was not statistically significant(P>0.05).Conclusion The combination of aspirin and clopidogrel combined with Shuxuetong in the treatment of ACI patients has a significant effect,which can reduce the degree of nerve damage,improve the hemorheological indicators in the body,improve the quality of life of patients,and will not increase adverse reactions,with high safety.

Acute cerebral infarctionShuxuetongClopidogrelAspirinNeurological functionHemorheologySecurity

马启荣

展开 >

兰陵县人民医院脑血管病科,山东临沂 276000

急性脑梗死 疏血通 氯吡格雷 阿司匹林 神经功能 血液流变学 安全性

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(9)